• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30

Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand

Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, announced that NovaTears®, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD), is now also available in Australia.

Read more →
Synaptive Medical's Modus V™, a digital robotic microscope

World Renowned Academic Medical Center Acquires Synaptive's Next-Generation Robotic System for Minimally Invasive Neurosurgery

Synaptive Medical Inc., a Toronto-based medical technology company, today announced that Duke University Medical Center has acquired its connected neurosurgery system. Modus V™, the cornerstone of the company’s automated robotic and imaging technology, sets the new standard for visual accuracy during surgery and advances minimally invasive cranial and spine procedures.

Read more →
The Phadia 200 benchtop instrument from Thermo Fisher Scientific

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions

A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is CE-marked, and the first installations are underway at select European sites.

Read more →